Back to search
Aggressive Variant Prostate Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Aggressive Variant Prostate Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Aggressive Variant Prostate Carcinoma trials you may qualify forTo find the best dose of ADI-PEG20 that can be given in combination with carboplatin and cabazitaxel to patients with AVPC.
This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prosta…
This study is a prospective, single arm II clinical trial. The main objective of the study is to evaluate the efficacy and safety of the combination of Sacituzu…
It is a Phase 2 clinical trial of Pembrolizumab in combination with Carboplatin and Cabazitaxel in Aggressive Variant Metastatic Castration Resistant Prostate C…
This Phase 2 study will investigate the safety and clinical activity of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies…
This phase Ib trial studies the side effects and best dose of DS3201 when given together with and ipilimumab for the treatment of patients with prostate, urothe…